Eden Research (LON:EDEN) Shares Up 10.5% – Here’s Why

Eden Research plc (LON:EDEN) shares rose 10.5% during trading on Friday. The stock traded as high as GBX 3.90 and last traded at GBX 3.43. Approximately 6,729,103 shares traded hands during trading, an increase of 988% from the average session volume of 618,734 shares. The stock had previously closed at GBX 3.10.

Eden Research Price Performance

The company has a debt-to-equity ratio of 5.41, a quick ratio of 2.42 and a current ratio of 1.95. The firm has a fifty day simple moving average of GBX 2.56 and a 200 day simple moving average of GBX 3.01. The company has a market capitalization of £27.52 million, a PE ratio of -7.73 and a beta of 1.55.

Eden Research (LON:EDEN) last issued its earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share for the quarter. Eden Research had a negative return on equity of 16.16% and a negative net margin of 50.43%. Equities analysts anticipate that Eden Research plc will post -66.00 EPS for the current year.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.